dc.creatorSampaio-Barros, P D
dc.creatorCosta-Paiva, L
dc.creatorFilardi, S
dc.creatorSachetto, Z
dc.creatorSamara, A M
dc.creatorMarques-Neto, J F
dc.date
dc.date2015-11-27T13:02:06Z
dc.date2015-11-27T13:02:06Z
dc.date.accessioned2018-03-29T01:00:50Z
dc.date.available2018-03-29T01:00:50Z
dc.identifierClinical And Experimental Rheumatology. v. 23, n. 2, p. 180-4
dc.identifier0392-856X
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/15895887
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/196261
dc.identifier15895887
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1296494
dc.descriptionTo analyse the results of bone densitometry in patients with systemic sclerosis (SSc), evaluating the prognostic factors of low bone mineral density (BMD) in fertile and postmenopausal patients, and comparing to a control healthy group. Cross-sectional study analysing 61 female SSc patients, aged 25 to 51 years, who performed a bone densitometry using dual x-ray absorptiometry. BMD values (lumbar spine, femoral neck, Ward and trochanter) infertile and postmenopausal patients were compared according to SSc clinical variant (limited and diffuse), race, previous use of drugs (corticosteroids and cyclophosphamide) and bone mass index (BMI). These results were compared with 47 fertile and 60 postmenopausal healthy women; multivariate linear regression analysis was used to study the influence of the variables of interest in the BMD results. Twenty-seven SSc patients presented osteopenia and 14 densitometric osteoporosis. No statistical association was found between BMD values and SSc clinical variants, race and previous use of corticosteroids and cyclophosphamide, in the fertile and in the postmenopausal groups. Fertile SSc patients were paired by age and race with the control group, but BMI (p = 0.035) was significantly lower in the SSc group. BMD values of lumbar spine (p = 0.070, statistical trend), femoral neck (p = 0.003), Ward (p < 0.001) and trochanter (p = 0.003) were significantly lower in the SSc group. Postmenopausal SSc patients were paired by age and race with the control group, but BMI (p < 0.001) was also significantly lower in the SSc group. Age at menopause (p = 0.006) was also significantly lower and time from menopause (p < 0.001) was significantly higher in the SSc group. BMD values of femoral neck (p < 0.001), Ward (p < 0.001) and trochanter (p = 0.001) were significantly lower in the SSc group. Multivariate linear regression analysis showed that BMI was the main variable influencing BMD in the fertile and postmenopausal groups. In the present study, BMD results in fertile and postmenopausal SSc patients were independent of the SSc clinical variants, race and previous use of corticosteroids and cyclophosphamide. A low BMD in appendicular sites was observed infertile and postmenopausal SSc patients when compared to a control healthy group, associated to a low BMI.
dc.description23
dc.description180-4
dc.languageeng
dc.relationClinical And Experimental Rheumatology
dc.relationClin. Exp. Rheumatol.
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAbsorptiometry, Photon
dc.subjectAdult
dc.subjectBone Density
dc.subjectBone And Bones
dc.subjectCross-sectional Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectLinear Models
dc.subjectMiddle Aged
dc.subjectMultivariate Analysis
dc.subjectOsteoporosis, Postmenopausal
dc.subjectPostmenopause
dc.subjectPrognosis
dc.subjectScleroderma, Diffuse
dc.subjectScleroderma, Limited
dc.titlePrognostic Factors Of Low Bone Mineral Density In Systemic Sclerosis.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución